Search
On November 20, 2025, Germany's Merck Group unveiled a strategic partnership with U.S.-based Varro Health, headquartered in Boston. The collaboration aims to leverage Varro Health's drug research capabilities for joint investigations into Parkinson's disease and associated conditions. This partnership holds the potential to surpass $3 billion in value, encompassing upfront fees, milestone payments, royalty fees, and research and development (R&D) funding support. Established in 2019, Varro Health specializes in facilitating drug discovery and development through cutting-edge data analysis and artificial intelligence (AI) technologies. Its research foundation is built upon an extensive repository of over 17 million patient medical records and biological samples.
-
C114 Communication Network -
Communication Home
